Connect with us

Business

Pfizer and BioNTech to request emergency authorization from FDA for Covid vaccine – CNBC

The FDA process is expected to take a few weeks, and an advisory committee meeting to review the vaccine has been tentatively scheduled for early December.

Published

on

post featured image
ADVERTISEMENT

Pfizer and BioNTech will apply Friday for an emergency use authorization from the Food and Drug Administration for their coronavirus vaccine.
If Pfizer’s application is approved, the vaccine will likely be limited and rolled out in phases, with health-care workers, the elderly and people with underlying health conditions getting the first inoculations. Essential workers, teachers and people in homeless shelters and prisons would likely be next, followed by children and young adults.
The FDA process…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

post featured image
Tesla is now under NHTSA scrutiny over Model S/X suspension after disputing recall in China – Electrek
post featured image
Dow Jones Futures Rise Amid Coronavirus Vaccine News, Bitcoin Falls; Tesla Suspension Probe Begins – Investor’s Business Daily
post featured image
Tesla and Volkswagen to compete with new affordable electric cars at ~$25,000 to $30,000 – Electrek